4 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) is the most widely used formula for eGFR in the UK. This formula considers multiple factors that can influence creatinine production ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Risk stratification by two-dimensional information on eGFR and proteinuria can improve the prediction of progression to ESRD; revision of CKD classification by including albuminuria, particular in ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm ...

Semaglutide was also found to be superior to placebo for the confirmatory secondary endpoints, which included annual rate of change in eGFR (CKD-EPI), time to occurrence of a major adverse CV ...

The J-shaped relationship between the biomarker and CKD progression was unaffected by age, baseline eGFR, or 24-hour proteinuria. According to Dr Bolignano’s team, urinary marinobufagenin “may ...

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

controls, with an annual eGFR change of –6.65 mL/min/1.73 m² vs. –2.61 mL/min/1.73 m², respectively. Female sex and older age were positively associated with CKD incidence among participants ...